National Health Investors (NHI) FY2017 results: revenue $279 million, up 12.1% on the year
National Health Investors Inc. (NHI) reported revenue of $279 million for fiscal 2017, the year ended 31 December 2017, up 12.1% on the year before. Net income was $159 million, up 5.2%, and diluted earnings per share $3.87. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2018.
Revenue
$279 million
+12.1% on the year
FY2010FY2017
Operating margin
54.4%
47.8% a year earlier
FY2010FY2017
Net income
$159 million
+5.2% on the year
FY2010FY2017
Diluted EPS
$3.87
0.0% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
279
248
229
+12.1%
Operating income
151
119
150
+27.6%
Operating margin
54.4%
47.8%
65.6%
Interest expense
46.3
43.1
37.6
+7.5%
Pre-tax income
151
119
127
+27.6%
Income tax
0.1
0.9
-0.6
-85.5%
Effective tax rate
0.1%
0.7%
-0.5%
Net income
159
152
149
+5.2%
Net margin
57.2%
61.0%
65.0%
Diluted EPS
$3.87
$3.87
$3.95
0.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
198
177
164
+12.1%
Capital expenditure
176
395
124
-55.5%
Free cash flow
22.3
-218
40.3
Free cash flow margin
8.0%
-87.8%
17.6%
Cash from investing
-164
-330
-136
Cash from financing
-35.1
144
-18.1
Share-based compensation
2.6
1.7
2.1
+50.8%
Dividends paid
153
138
125
+10.7%
Dividend per share
$3.80
$3.60
$3.40
+5.6%
Diluted shares, weighted
41m
39m
38m
+5.1%
Shares outstanding at period end
42m
40m
38m
+4.2%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
1,322
1,210
1,133
+9.3%
Non-controlling interest
n/a
0.0
9.2
Debt
1,145
1,116
914
+2.6%
Other liabilities
78.2
78.1
76.3
+0.2%
Total liabilities and equity
2,546
2,404
2,133
+5.9%
Fixed assets
2,286
2,160
1,837
+5.8%
Loans
141
133
134
+6.0%
Cash and equivalents
3.1
4.6
13.1
-33.9%
Receivables
2.4
9.2
3.3
-73.6%
Other assets
113
96.5
146
+17.2%
Total assets
2,546
2,404
2,133
+5.9%
10-K for the year ended 31 December 2017, filed 16 February 2018: the filing.